Manitobans 12 and up eligible to receive Omicron-specific COVID-19 booster that targets BA.4 and BA.5 variants – CBC

New Pfizer vaccine to arrive by end of this week, province says

Oct 13, 2022

Manitoba will receive the newly approved Pfizer Omicron-specific COVID-19 vaccine, which targets Omicron BA.4 and BA.5 subvariants, by the end of this week, the province said in a news release Thursday.

It will be offered to anyone 12 or older.

Health Canada approved the use of the Pfizer bivalent vaccine on Oct. 7.

Previously, Manitobans 18 or older were eligible for the Moderna bivalent vaccine, which targets the original strain of COVID-19 and the first Omicron variant, BA.1.

Children age 12 to 17 will receive the newly approved Pfizer vaccine, because it is the only one approved for that aged group.

Manitobans can expect the Pfizer booster to be at most vaccine providers by Oct. 24, the province said.

Read more: https://www.cbc.ca/news/canada/manitoba/pfizer-bivalent-booster-manitoba-eligiblity-1.6615485